Sinopharm
1099.HK
#2861
Rank
โ‚น587.16 B
Marketcap
โ‚น188.16
Share price
-2.70%
Change (1 day)
-11.09%
Change (1 year)
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.

Revenue for Sinopharm (1099.HK)

Revenue in 2025: โ‚น7.822 Trillion

According to Sinopharm's latest financial reports the company's current revenue (TTM ) is โ‚น7.822 Trillion. In 2025 the company made a revenue of โ‚น7.822 Trillion an increase over the revenue in the year 2024 that were of โ‚น7.620 Trillion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Sinopharm from 2006 to 2025

Annual revenue

Year Revenue Change
2025โ‚น7.822 T2.65%
2024โ‚น7.620 T-5.1%
2023โ‚น8.030 T5.42%
2022โ‚น7.617 T-2.1%
2021โ‚น7.780 T16.85%
2020โ‚น6.658 T14.95%
2019โ‚น5.792 T21.52%
2018โ‚น4.766 T5.93%
2017โ‚น4.499 T27.22%
2016โ‚น3.537 T5.37%
2015โ‚น3.356 T9.14%
2014โ‚น3.075 T17.22%
2013โ‚น2.623 T25.94%
2012โ‚น2.083 T34.61%
2011โ‚น1.547 T55.34%
2010โ‚น996.26 B35.79%
2009โ‚น733.69 B37.56%
2008โ‚น533.37 B31.43%
2007โ‚น405.83 B40.26%
2006โ‚น289.34 B